Application no. and date | 03749093.5 (espacenet) (Federated) (European Patent Register), 20030820 | Patent/reg. no. and date | DK/EP 1530469, 20090225 | Publication date | 20050518 | Priority no. and date | US 404980 P, 20020820 | EP pub. no. and date |
EP 1530469 20050518 | Effective date | | Applicant/owner | EURO-CELTIQUE S.A., 1, rue Jean Piret 2350 Luxembourg , LU | Applicant ref. no. | P80901174DK00E | Inventor | SHEVCHUK, Ihor, 11 Shelburne Avenue
Yonkers, NY 10710, US, REIDENBERG, Bruce, 1 Stonycrest Road
Rye, NY 01580, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/445 (2006.01) , A61K 31/4468 (2006.01) , A61K 9/70 (2006.01) , A61P 25/36 (2006.01) | Title | Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist | Int. application no. | US2003026132 | Int. publication no. | WO2004017941 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|